Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Cap Regulatory News (INOV)

Share Price Information for Schroders Cap (INOV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.15
Bid: 11.70
Ask: 12.30
Change: 0.45 (3.85%)
Spread: 0.60 (5.128%)
Open: 12.00
High: 12.15
Low: 11.70
Prev. Close: 11.70
INOV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Tessian

31 Oct 2023 12:56

RNS Number : 8997R
Schroders Capital Global Innovation
31 October 2023
 

 

Schroders Capital Global Innovation Trust plc

Sale of Tessian

 

Schroders Capital Global Innovation Trust plc (the "Company") announces that its portfolio company Tessian, the innovative email cybersecurity company, has entered into a definitive agreement to be acquired by Proofpoint - a people-centric cybersecurity and compliance company. The agreement is expected to close in late 2023 to early 2024, subject to customary closing conditions and required regulatory approvals. Details of the transaction were not disclosed.

In May 2021, the Company made a $6.75m investment into Tessian as part of its $65m Series C funding round to accelerate its mission of quantifying and preventing human risk in enterprises across the globe. Tessian's Series C round was led by March Capital, a U.S.-based venture capital and growth equity firm, with participation from existing shareholders including Sequoia Capital, Accel, Balderton Capital and Latitude.

Tim Creed, Lead Portfolio Manager, and Harry Raikes, Co-Portfolio Manager commented: " It has been a pleasure working closely with Tim Sadler, CEO, and the Tessian team over the past two years and we wish them all the best in their next chapter. We hope to be able to share more details with the Company's investors when the transaction closes."

 

Enquiries:

Schroder Investment Management Limited

Shilla Pindoria (Company Secretary)

0207 658 6000

Augustine Chipungu (Press)

0207 658 2106

John Spedding (Head of Investment Trusts)

0207 658 3206

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFLFEFISLLVIV
Date   Source Headline
31st May 20245:08 pmRNSTotal Voting Rights
31st May 20244:45 pmRNSTransaction in Own Shares
30th May 20244:36 pmRNSTransaction in Own Shares
29th May 20245:01 pmRNSTransaction in Own Shares
28th May 20244:35 pmRNSTransaction in Own Shares
24th May 20241:56 pmRNSTransaction in Own Shares
23rd May 20245:21 pmRNSTransaction in Own Shares
23rd May 20247:00 amRNSQuarterly NAV Announcement - 31 March 2024
22nd May 20245:11 pmRNSTransaction in Own Shares
22nd May 20244:32 pmRNSResult of AGM
21st May 20244:35 pmRNSTransaction in Own Shares
20th May 20244:17 pmRNSTransaction in Own Shares
17th May 20243:52 pmRNSTransaction in Own Shares
16th May 20244:37 pmRNSTransaction in Own Shares
15th May 20244:16 pmRNSTransaction in Own Shares
14th May 20241:50 pmRNSTransaction in Own Shares
13th May 20244:38 pmRNSTransaction in Own Shares
10th May 20244:53 pmRNSTransaction in Own Shares
9th May 20244:19 pmRNSTransaction in Own Shares
8th May 20244:24 pmRNSTransaction in Own Shares
7th May 20245:42 pmRNSTransaction in Own Shares
7th May 20247:30 amRNSInvestment in Memo Therapeutics
3rd May 20244:19 pmRNSTransaction in Own Shares
2nd May 20244:15 pmRNSTransaction in Own Shares
1st May 20244:17 pmRNSTransaction in Own Shares
30th Apr 20245:08 pmRNSTotal Voting Rights
30th Apr 20244:33 pmRNSTransaction in Own Shares
29th Apr 20244:39 pmRNSTransaction in Own Shares
26th Apr 20244:29 pmRNSTransaction in Own Shares
25th Apr 20244:34 pmRNSTransaction in Own Shares
24th Apr 20245:30 pmRNSTransaction in Own Shares
23rd Apr 20245:17 pmRNSTransaction in Own Shares
22nd Apr 20244:30 pmRNSTransaction in Own Shares
19th Apr 20243:16 pmRNSTransaction in Own Shares
18th Apr 20244:45 pmRNSTransaction in Own Shares
17th Apr 20244:31 pmRNSTransaction in Own Shares
16th Apr 20244:40 pmRNSTransaction in Own Shares
15th Apr 20244:09 pmRNSTransaction in Own Shares
12th Apr 20243:37 pmRNSTransaction in Own Shares
11th Apr 20244:24 pmRNSTransaction in Own Shares
10th Apr 20245:17 pmRNSTransaction in Own Shares
9th Apr 20244:56 pmRNSTransaction in Own Shares
8th Apr 20244:21 pmRNSTransaction in Own Shares
8th Apr 202412:19 pmRNSResults analysis from Kepler Trust Intelligence
4th Apr 20244:37 pmRNSTransaction in Own Shares
3rd Apr 20243:53 pmRNSTransaction in Own Shares
2nd Apr 20244:07 pmRNSTransaction in Own Shares
2nd Apr 20241:19 pmRNSChange to Frequency of NAV Reporting
2nd Apr 202411:15 amRNSNet Asset Value(s)
28th Mar 20245:02 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.